Hims eyes growth in its weight loss business, despite end of semaglutide shortage

Hims & Hers expects revenue from its weight loss business to soar in 2025, even though a recent FDA move could make it tougher for pharmacies and telehealth companies to offer certain compounded obesity drugs ...

Feb 25, 2025 - 15:32
 0
Hims eyes growth in its weight loss business, despite end of semaglutide shortage
Hims & Hers expects revenue from its weight loss business to soar in 2025, even though a recent FDA move could make it tougher for pharmacies and telehealth companies to offer certain compounded obesity drugs ...